ncomms9576

BRIC Antibody (3F10) Summary

    Immunogen
    ATP8B1 (NP_005594.1 471 a.a. – 551 a.a.) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. INGQIYGDHRDASQHNHNKIEQVDFSWNTYADGKLAFYDHYLIEQIQSGKEPEVRQFFFLLAVCHTVMVDRTDGQLNYQAA
    Specificity
    Reacts with ATPase, class I, type 8B, member 1.
    Isotype
    IgG1 Kappa
    Clonality
    Monoclonal
    Host
    Mouse
    Gene
    ATP8B1
    Purity
    Protein A purified
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        ELISA
    Application Notes
    This antibody is reactive against recombinant protein in ELISA.

Packaging, Storage & Formulations

    Storage
    Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
    Buffer
    PBS (pH 7.4)
    Preservative
    No Preservative
    Purity
    Protein A purified

Notes

Quality control test: Antibody Reactive Against Recombinant Protein.

This product is produced by and distributed for Abnova, a company based in Taiwan.

Alternate Names for BRIC Antibody (3F10)

      ATPase class I type 8B member 1
      ATPase, aminophospholipid transporter, class I, type 8B, member 1
      ATPase, class I, type 8B, member 1
      ATPICPFIC1
      BRIC
      EC 3.6.3
      EC 3.6.3.1
      Familial intrahepatic cholestasis type 1
      FIC1phospholipid-transporting ATPase IC
      PFICE1-E2 ATPase
      probable phospholipid-transporting ATPase IC

Background

This gene encodes a member of the P-type cation transport ATPase family, which belongs to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to another. Mutations in this gene may result in progressive familial intrahepatic cholestasis type 1 and in benign recurrent intrahepatic cholestasis. [provided by RefSeq]

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

product targets : EAAT3 inhibitors

Related Post